Product Information
MIDAZOLAM HCL 5 MG/ML VIAL is a generic product labeled by Hospira Inc., priced at $1.2259 per ML under NDC 00409230849. Its NADAC has been published 180 times since Jan 22, 2014.
FDA first approved this application on Jul 22, 2002. Its Orange Book therapeutic-equivalence code is AP.
Strength
5 mg/mL
Manufacturer
Hospira Inc.NDC
00409230849
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
MIDAZOLAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075857FDA Approved
7/22/2002
TE Code
AP
On Market Since
6/14/2005
Pharmacological Classes
Price Statistics
The NADAC for MIDAZOLAM HCL 5 MG/ML VIAL has been published 180 times since Jan 22, 2014, and over the history we have for it it has risen 22.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2259 per ML |
|---|---|
| All-time high | $1.2259 (Sep 30, 2026) |
| All-time low | $0.9764 (Dec 17, 2025) |
| 52-week high | $1.2259 |
| 52-week low | $0.9764 |
| Median price | $1.0035 |
| Average price | $1.0273 |
| Largest weekly change | +6.5% (Mar 18, 2026) |
| Weeks tracked | 180 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 69% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hospira Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
MIDAZOLAM HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIDAZOLAM HCL 5 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for MIDAZOLAM HCL 5 MG/ML VIAL, manufactured by Hospira Inc., is $1.2259 per ML (NDC 00409230849), effective Sep 30, 2026.
How has the price of MIDAZOLAM HCL 5 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for MIDAZOLAM HCL 5 MG/ML VIAL has risen 22.2%. It has been tracked across 180 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for MIDAZOLAM HCL 5 MG/ML VIAL?
Since Jan 22, 2014, the NADAC for MIDAZOLAM HCL 5 MG/ML VIAL has ranged from a low of $0.9764 (Dec 17, 2025) to a high of $1.2259 (Sep 30, 2026), with a median of $1.0035 per ML.
Are there cheaper alternatives to MIDAZOLAM HCL 5 MG/ML VIAL?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MIDAZOLAM HCL 50 MG/10 ML VIAL, is $0.3817 per ML — about 69% below MIDAZOLAM HCL 5 MG/ML VIAL.
Who manufactures MIDAZOLAM HCL 5 MG/ML VIAL?
MIDAZOLAM HCL 5 MG/ML VIAL (NDC 00409230849) is labeled by Hospira Inc., and CMS classifies it as a generic product.